William S John1, Li-Tzy Wu1,2,3,4. 1. a Department of Psychiatry and Behavioral Sciences , Duke University Medical Center , Durham , North Carolina , USA. 2. b Department of Medicine, Division of General Internal Medicine , Duke University Medical Center , Durham , North Carolina , USA. 3. c Duke Clinical Research Institute , Duke University Medical Center , Durham , North Carolina , USA. 4. d Center for Child and Family Policy, Sanford School of Public Policy , Duke University , Durham , North Carolina , USA.
Abstract
BACKGROUND: The emergency department (ED) is well-suited as an opportunity to increase treatment access for prescription opioid use disorder (POUD). We examined sex differences in ED utilization among individuals with POUD to understand potential sex-specific treatment barriers and needs. METHODS: Data from the 2005-2014 National Surveys on Drug use and Health were analyzed to examine the prevalence and correlates of past-year ED utilization among male and female adults aged 18 or older with POUD (n = 4412). RESULTS: Overall, 58.2% of adults with POUD reported past-year ED utilization. Adjusted logistic regression revealed that females (vs. males) with POUD were more likely to report past-year ED utilization. Among females with POUD, older age, lower income, obtaining opioids from a physician, major depressive episode, and greater POUD severity were associated with increased odds of ED utilization. Among males with POUD, public insurance and obtaining opioids from a physician were associated with ED utilization. A larger proportion of males with POUD reporting ED use had multiple substance use disorders than those with no ED use. Treatment history (lifetime or past-year) for alcohol, drugs, or opioid use was associated with increased odds of ED use among males and females with POUD. Conclusions/Importance: Males and females with POUD presenting to the ED may have distinct predisposing, enabling, and need-related correlates. Sex-specific screening and intervention strategies may be useful to maximize the utility of the ED to address POUD.
BACKGROUND: The emergency department (ED) is well-suited as an opportunity to increase treatment access for prescription opioid use disorder (POUD). We examined sex differences in ED utilization among individuals with POUD to understand potential sex-specific treatment barriers and needs. METHODS: Data from the 2005-2014 National Surveys on Drug use and Health were analyzed to examine the prevalence and correlates of past-year ED utilization among male and female adults aged 18 or older with POUD (n = 4412). RESULTS: Overall, 58.2% of adults with POUD reported past-year ED utilization. Adjusted logistic regression revealed that females (vs. males) with POUD were more likely to report past-year ED utilization. Among females with POUD, older age, lower income, obtaining opioids from a physician, major depressive episode, and greater POUD severity were associated with increased odds of ED utilization. Among males with POUD, public insurance and obtaining opioids from a physician were associated with ED utilization. A larger proportion of males with POUD reporting ED use had multiple substance use disorders than those with no ED use. Treatment history (lifetime or past-year) for alcohol, drugs, or opioid use was associated with increased odds of ED use among males and females with POUD. Conclusions/Importance: Males and females with POUD presenting to the ED may have distinct predisposing, enabling, and need-related correlates. Sex-specific screening and intervention strategies may be useful to maximize the utility of the ED to address POUD.
Entities:
Keywords:
National Survey on Drug Use and Health; Opioid; emergency department; opioid use disorder
Authors: Dario Tedesco; Steven M Asch; Catherine Curtin; Jennifer Hah; Kathryn M McDonald; Maria P Fantini; Tina Hernandez-Boussard Journal: Health Aff (Millwood) Date: 2017-10-01 Impact factor: 6.301
Authors: Claire B Simon; Judith I Tsui; Joseph O Merrill; Addy Adwell; Elsa Tamru; Jared W Klein Journal: Drug Alcohol Depend Date: 2017-10-10 Impact factor: 4.492
Authors: Jeffrey H Coben; Stephen M Davis; Paul M Furbee; Rosanna D Sikora; Roger D Tillotson; Robert M Bossarte Journal: Am J Prev Med Date: 2010-05 Impact factor: 5.043
Authors: R Kathryn McHugh; Elise E Devito; Dorian Dodd; Kathleen M Carroll; Jennifer Sharpe Potter; Shelly F Greenfield; Hilary Smith Connery; Roger D Weiss Journal: J Subst Abuse Treat Date: 2013-01-11
Authors: Jessica A Dreifuss; Margaret L Griffin; Katherine Frost; Garrett M Fitzmaurice; Jennifer Sharpe Potter; David A Fiellin; Jeffrey Selzer; Mary Hatch-Maillette; Susan C Sonne; Roger D Weiss Journal: Drug Alcohol Depend Date: 2013-01-18 Impact factor: 4.492